In vitro studies have demonstrated that two different metabolic pathways, glutathione conjugation mediated by the glutathione S-transferases and microsomal oxidation, may be involved in the genotoxicity and carcinogenicity of 1,2-dichloroethane (DCE). To evaluate the importance of microsomal oxidative metabolism in the bioactivation of DCE in vivo, male B6C3F1 mice were pretreated with piperonyl butoxide (PIB), an inhibitor of microsomal oxidative metabolism, and the effect of this pretreatment on the extent of hepatic DNA damage produced by DCE was determined 4 hr after DCE administration. The in vivo genotoxicity of 2-chloroethanol, a product of the microsomal oxidative metabolism of DCE, was also investigated. Hepatic DNA damage was measured with a sensitive, alkaline DNA unwinding assay for the presence of single-strand breaks and alkali-labile lesions in DNA. Pretreatment of mice with PIB to inhibit microsomal oxidative metabolism significantly potentiated the hepatic DNA damage observed 4 hr after a single, 200-mg/kg, ip dose of DCE. Treatment of mice with single, ip doses of 2-chloroethanol as high as 1.2 mmol/kg failed to produce any evidence of single-strand breaks and/or alkali-labile lesions in hepatic DNA. When diethyl maleate (DEM) was used to deplete hepatic ghrtathione levels prior to administration of 2-chloroethanol, the acute hepatotoxicity of 2-chloroethanol was potentiated but again there was no evidence of hepatic DNA damage. These results indicate that microsomal, oxidative metabolism of DCE to 2-chloroethanol and/or 2 chloroacetaldehyde is not responsible for the hepatic DNA damage observed in these studies after DCE administration. 8 1985 Academic press. IW.
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1,2-Dichloroethane (DCE) is an economically important, chlorinated, aliphatic hydrocarbon used primarily in the production of vinyl chloride and other halogenated organics and as a solvent, gasoline additive, and component of fumigants. The National Cancer Institute (USDHEW, 1978) has determined that DCE is carcinogenic to Osborne-Mendel rats and B6C3FI mice when administered ' Supported by NIH Grant 5 T32 ES07062. 'Present address and to whom al1 correspondence should be addressed: Merck Institute for Therapeutic Research, Merck Sharp and Dohme Research Laboratories, Building 44-1, West Point, Pa. 19486. chronically by gavage. A second bioassay of DCE for possible carcinogenicity by the inhalation route of exposure failed, however, to produce any evidence for the carcinogenicity of DCE in Sprague-Dawley rats or Swiss mice (Maltoni et al., 1980) . The carcinogenic potential of DCE has, therefore, remained somewhat speculative and may, as the results of the bioassays suggest, be dependent on the strains of test animals or the route of exposure (Hooper et al., 1980) .
Positive results from several short-term in vitro test systems for mutagenicity (Rannug, 1980; Guengerich et al., 1980; (Banerjee and van Duuren, 1979; Banerjee et al., 1980; Guengerich et al., 1980; Perocco and Prodi, 1981) have provided further evidence of the carcinogenic potential of DCE. More recent studies have also confirmed the genotoxic potential of DCE in vivo (Reitz et al., 1982; Storer et al., 1982 Storer et al., , 1984 Storer and Conolly, 1983) . The in vitro studies cited above indicated that DCE requires metabolic activation to exhibit genotoxic activity and identified two different metabolic pathways, glutathione conjugation and microsomal oxidation, as potentially significant sources of mutagenic and/or carcinogenic metabolites from DCE. The glutathione Stransferase-mediated conjugation of DCE with glutathione produces reactive compounds, presumably half-sulfur mustards, which have been shown to be mutagenic toward Salmonella typhimurium strains TA 1535 and TA 100 (Rannug et al., 1978; Guengerich et al., 1980; van Bladeren et al., 198 1) . The results from these mutagenicity studies and an in vitro DNA binding study (Guengerich et al., 1980) have suggested that the primary route of bioactivation for DCE may be the glutathione conjugation pathway.
In vitro DNA binding experiments with DCE (Banerjee and van Duuren, 1979; Banerjee et al., 1980; Guengerich et al., 1980) have, however, also provided evidence for the involvement of microsomal oxidative metabolism in the bioactivation of DCE to a genotoxic metabolite.
2Chloroacetalde-hyde, which is mutagenic in the Ames test without metabolic activation (McCann et al., 1975) , is believed to be the active metabolite of DCE formed by this pathway. DNA binding studies in vitro have shown that 2-chloroacetaldehyde reacts directly with adenine and cytosine bases to form cyclic etheno adducts (Barrio et al., 1972; Lee and Wetmur, 1973; Guengerich et al., 1981) . Further evidence for the possible importance of 2-chloroacetaldehyde binding to DNA comes from studies demonstrating the presence of 3-pethenodeoxycytidine (Green and Hathway, 1978) and 7-N-(2-oxoethyl)guanine (Laib et al., 1981) in hydrolysates of DNA from rats exposed to vinyl chloride. Vinyl chloride metabolism in vitro has been shown to result in 2-chloroacetaldehyde production by rearrangement of 2-chloroethylene oxide (Bonse et al., 1975) a product of microsomal oxidative metabolism of vinyl chloride (Barbin et al,, 1975) . More recently, 2-chloroacetaldehyde pretreatment of nucleotide polymers has been shown to induce errors during DNA synthesis in vitro (Hall et al., 1981) . There is, therefore, considerable evidence to suggest that microsomal oxidative metabolism of DCE to 2-chloroacetaldehyde may also be involved in the genotoxicity and carcinogenicity of DCE.
Recent sudies in our laboratory have shown that DNA single-strand breaks and/or alkalilabile lesions can be detected in hepatic DNA isolated from mice 4 hr after treatment with a single, po or ip dose of DCE (Storer et al., 1982; Storer and Conolly, 1983) . This type of DNA damage was not, however, detectable in mice exposed by inhalation to concentrations of DCE as high as 500 ppm for 4 hr (Storer et al., 1984) . In the present study, the role of microsomal oxidative metabolism of DCE in the formation of the reactive metabelite(s) responsible for this type of hepatic DNA damage was investigated in vivo in two different ways. First, the effect of a potent inhibitor of microsomal oxidative metabolism, piperonyl butoxide (PIB), on the hepatic DNA damage produced by DCE was studied. Second, the potential of 2-chloroethanol to produce single-strand breaks and/or alkalilabile lesions in hepatic DNA from mice treated in vivo was investigated. 2Chloroeth-anol is metabolized by alcohol dehydrogenases to 2-chloroacetaldehyde (Blair and Valee, 1966; Johnson, 1967) and was employed in these studies as a means of generating 2-chloroacetaldehyde intracellularly in vivo. The acute toxicity of 2-chloroacetaldehyde in vivo and evidence of its reactivity at the site of administration (Lawrence et al., 1972) indicated that it would not be feasible to inves-tigate the in vivo genotoxicity of this compound directly.
METHODS
Animals. Male B6C3Fi mice were purchased from Charles River Breeding Laboratories, Inc., Portage, Michigan, or were bred in our laboratories from C3H male and C57BL female mice obtained from Charles River Breeding Laboratories, Inc. Mice were 6 to 9 weeks of age at the time of experiments and had been maintained in our laboratory for at least 3 weeks prior to use. Mice were housed 8 to 10 per cage, bedded in soft wood chips, and fed Purina rodent chow and water ad libitum until the morning of experiments. Animal rooms were maintained at 22 to 24°C with a 12 hr light-dark cycle. DCE and PIB were administered ip in corn oil in a constant volume of 5 and 1 ml/kg, respectively. 2Chloroethanol was dissolved in 0.85% NaCl and administered ip in a constant volume of 5 ml/ kg. Diethyl maleate (DEM) was administered ip (neat). Carbon tetrachloride (CCh) was given ip in corn oil in a constant volume of 5 ml/kg.
Chemicals. DCE (glass distilled) was purchased from MCB Manufacturing Chemists, Inc., Cincinnati, Ohio. Its purity was checked by gas chromatography (flame ionization detector) and found to be greater than 99.9%. PIB was obtained from ICN Pharmaceuticals, Plainview, New York. 2Chloroethanol and diaminobenzoic acid dihydrcchloride were purchased from Aldrich Chemicals, Milwaukee, Wisconsin. DEM, glutathione reductase, reduced glutathione (GSH), oxidized ghttathione (GSSG), NADH, and NADPH were all obtained from the Sigma Chemical Company, St. Louis, Missouri. Hexobarbital was purchased from Winthrop Steams Inc., New York, New York, and 2-vinylpyridine from Fluka AG, Buchs, Switzerland. The hydroxylapatite (Bio-Gel HTP, DNA grade) was obtained from Bio-Rad Laboratories, Richmond, California.
Hexobarbital sleeping time. Hexobarbital (free acid, 125 mg) was added to 1.5 ml of 0.85% NaCI, and 5-to 25 ~1 aliquots of 5.0 N NaOH were added until the hexobarbital dissolved. The solution was then diluted to 2.0 ml. Mice were injected ip with 2.0 ml/kg of this solution (125 mg/kg), and the hexobarbital sleeping time was measured as the time from loss of the righting reflex to its restoration, as previously described (Vesell, 1968) .
Hepatic glututhione levels. Oxidized glutathione (GSSG) and total glutathione (GSSG and GSH) per gram of liver tissue were determined by a ghrtathione reductase recycling assay (Tietze, 1969 ). The procedure, described below, is a modification of the techniques developed by Griffith (1980) and Akerboom and Sies (1981) . Mice treated as described in the text were killed by cervical dislocation and the livers removed and homogenized in 9 vol of cold 1.0 M HCIO., and 2.0 mM EDTA-Na,.
Homogenates were centrifuged at 3500g for 15 min at 4°C and the supematant fractions diluted either l/10 for determination of GSSG or l/100 for determination of total glutathione (GSH and GSSG). Aliquots (690 ~1) of these dilutions were then transferred to separate tubes containing 410 ~1 of 2.0 M KOH and 0.3 M Hepes; the precipitate was pelleted by centrifugation for 15 min at 35008. For the determination of GSSG, 10.5 ~1 of 2-vinylpyridine was added to each tube with the 2.0 M KOH. 0.3 M Hepes to derivatize the GSH. The supernatant fraction in each tube was then assayed for glutathione by the glutathione reductase recycling assay. An aliquot (700 ~1) of 0.1 M sodium phosphate, 5.0 mM EDTA-Naz buffer, pH 7.5, containing 0.3 mM NADPH, was transferred to a 1.5-ml cuvette containing 20 ~1 of 3.8 mM 5,5'dithiobis-2-nitrobenzoic acid (DTNB) in 0.1 M sodium phosphate, 5 mM EDTA-Na, buffer, pH 7.5, and 200 r.d of neutralized supematant fraction. To start the assay, 40 ~1 of GSH reductase (12.5 units/ml in 0.1 M sodium phosphate, 50 mM EDTA-Na2 buffer, pH 7.5) was added and the absorbance at 412 nm monitored for 5 min at 25°C. The glutathione content of the samples was then determined from standard curves for the rate of change of the absorbance at 412 nm for standards containing known amounts of GSSG or GSH. The GSH concentration in the samples was calculated as the difference between the total glutathione (GSH and GSSG) and oxidized ghttathione (GSSG) per gram of tissue.
Acute toxicity. To assess the acute toxicity of DCE and 2-chloroethanol alone and with PIB and DEM pretreatments, respectively, mice were treated as described in the text and killed 24 hr later. Feed but not water was removed during the interval between dosing and termination. Liver and kidneys were removed and weighed; blood was drawn for determination of serum enzyme levels. L-Iditol dehydrogenase (IDH, sorbitol dehydrogenase, EC 1.1.1.14) activity in serum was analyzed according to the method described by Conolly et al. (1979) and serum alanine aminotransferase (AAT, EC 2.6.1.2) activity by the method of Wroblewski and LaDue (1956) .
In vivo-in vitro genotoxicity assay. In vivo genotoxicity was determined with a sensitive in vivo-in vitro alkaline DNA unwinding assay for the presence of single-strand breaks and alkali-labile sites in hepatic DNA Conolly, 1983, 1984) . Mice were treated as described in the text and killed 4 hr later by cervical dislocation. Hepatic DNA damage measured as single-strand breaks in alkali has previously been shown to be maximal 4 hr after administration of a genotoxic 1,2dihaloethane, I ,2-dibromoethane (Nachtomi and Sarma, 1977) . Livers were removed and suspensions of hepatic nuclei prepared by gently mincing livers in cold 0.075 M NaCl and 0.024 M EDTA-Naz, pH 7.5. The presence of single-strand breaks and/or alkali-labile lesions in the hepatic DNA was then determined by alkaline DNA unwinding and hydroxylapatite batch chromatography as previously described Conolly, 1983, 1984) . For each sample of nuclei, assayed in duplicate, the fraction of the total DNA recovered which eluted from the hydroxylapatite as double-stranded DNA was calculated. Results for each animal were then expressed as a percentage of the mean value for the fraction of the DNA that is double stranded in the control group and results for each group as the mean and standard deviation of these percentages.
Statistical analysis. Mean and standard deviations were calculated for each experimental group. Significance testing was by one-way analysis of variance with multiple comparisons by the Bonferroni method (Neter and Wasserman, 1974) . Statistical significance was assumed at the p c 0.05 level.
RESULTS

Hexobarbital
sleeping times have previously been shown to be a convenient measure of microsomal cytochrome P-450-mediated, monooxygenase activity in vivo (Conney et al., 1960) . Results presented in Table 1 indicate that PIB, at the dose levels employed in these studies, significantly inhibited microsomal oxidative metabolism of hexobarbital as evidenced by the approximately lo-fold increase in observed hexobarbital sleeping times. Similar results for the effect of PIB on hexobarbital sleeping times in male mice have been reported earlier (Kamienski and Murphy, 1971) . Whereas DCE metabolism has previously been shown to be dependent on cytochrome P-450-mediated monooxygenase activity (Guengerich et al., 1980) and 'Significantly different from control (p < 0.05) by one-way analysis of variance (Neter and Wasserman, 1974). to be inhibited by the classic cytochrome P-450 inhibitors, SKF-525A and metyrapone (Guengerich et al., 1980) , these results indicate that the PIB pretreatment employed in these studies would be expected to have significantly inhibited microsomal oxidative metabolism of DCE in vivo.
The effect of PIB pretreatment on hepatic glutathione levels was also investigated in preliminary experiments to determine if the previously reported depletion of hepatic glutathione by PIB in mice (James and Harbison, 1982) would be observed at the dose levels required to inhibit microsomal oxidative metabolism. No significant changes in hepatic glutathione levels were observed, however, in groups of three mice 1.5, 3.0, or 4.5 hr after a single, 200-mg/kg dose of PIB. These results indicated that hepatic glutathione depletion would not be a significant confounding factor in the genotoxicity experiments.
Acute hepatotoxicity may under certain circumstances be a confounding factor in hepatic DNA damage studies where the endpoint employed is single-strand breaks in alkali (Sina et al., 1983) . We have previously found that a single, ip dose of CC& (25 pl/ kg) which produces evidence of severe hepatotoxicity at 24 hr did not have any significant effect on DNA strand integrity as early as 4 hr after treatment (Storer, et al., 1984) . Nevertheless, the acute hepatotoxicity of the treatment regimens employed in the in vivo genotoxicity studies reported here was investigated in separate experiments. Results presented in Table 2 indicate that neither DCE nor PIB, alone or in combination, was acutely hepatotoxic at the doses employed in these studies. Liver weight to body weight ratios were elevated after PIB treatment but this effect, reported previously (Philpot and Hodgson, 197 l) , is believed to be due to the inductive effect of PIB on microsomal enzymes rather than to acute hepatotoxicity.
The effect of PIB pretreatment on the extent of hepatic DNA damage produced by DCE is shown in Table 3 . Administration of PIB alone did not produce any evidence of (Neter and Wasserman, 1974) .
DNA strand breaks in alkali but, as previously reported (Storer and Conolly, 1983 ) DCE alone significantly decreased the fraction of a Male B6C3Fr mice were killed 4 hr after ip administration of DCE (200 mg/kg) or corn oil. PIB (200 mg/ kg) was injected ip I hr before DCE or corn oil.
' Values are X + SD. The mean value for the fraction double-stranded DNA in the control group was 0.637 f 0.040. Numbers of mice per group are in parentheses.
' Control minus treated. dSignificantly different from control (p G 0.05) by one-way analysis of variance with multiple comparisons by the Bonferroni method (Neter and Wasserman, 1974) .
'Significantly different from mice treated with DCE alone (p 4 0.05) by one-way analaysis of variance with multiple comparisons by the Bonferroni method (Neter and Wasserman, 1974) . the total DNA recovered as double-stranded DNA. However, when mice were pretreated with PIB, the genotoxic effect of DCE was potentiated. The fraction of the total DNA recovered as double-stranded DNA, expressed as a percentage of control, was significantly decreased in the PIB-pretreated animals after DCE administration. Thus, it would appear that microsomal, cytochrome P-450-mediated, oxidative metabolism is not the primary source of the genotoxic metabolite(s) responsible for this type of DNA damage.
Previous studies of the metabolism of DCE in viva in mice (Yllner, 1971) and rats (Reitz et al., 1982) indicated that oxidative metabolism is a major route of disposition for DCE. The identities of the major urinary metabolites recovered in these studies (chloroacetic acid, S-carboxymethylcysteine, thiodiacetic acid, and thiodiacetic acid sulfoxide) indicate that microsomal oxidative metabolism of DCE and subsequent conjugation of the oxidative metabolites with glutathione are involved in the generation of a significant fraction of these urinary metabolites. We have previously found significant depletion of hepatic glutathione levels in mice treated with DCE (Storer er al., 1982) . Since this depletion is probably due largely to the conjugation of glutathione with oxidative metabolites of DCE, the assumed inhibitory effect of PIB on DCE metabolism should be evident as a decrease in the extent of hepatic glutathione depletion. This phenomenon has been observed in PIB-pretreated mice dosed with 1,2-dibromoethane (Kluwe et al., 198 1) . Results presented in Fig. 1 indicate that PIB pretreatment does significantly inhibit the glutathione depleting effect of DCE at 1 hr after DCE administration but the magnitude of the effect is quite small. This may be evidence of a compensatory increase in the amount of DCE metabolized by the direct glutathione conjugation pathway after PIB pretreatment.
In the second series of experiments in this study, the in vivo genotoxicity of 2-chloroethanol was investigated. 2-Chloroethanol has been identified as a metabolite of DCE in vitro (Guengerich et al., 1980) and has been shown to be a substrate for alcohol dehydrogenases (Johnson, 1967; Guengerich et al., 1979) . Thus, in vivo administration of 2-chloroethanol would be expected to lead to the formation of 2-chloroacetaldehyde intracellularly in hepatocytes, the major target cell population in this study. Since 2-chloroacetaldehyde is more readily conjugated with glutathione than 2-chloroethanol (Johnson, 1966) , hepatic glutathione depletion is a convenient indicator of the extent of formation of 2-chloroacetaldehyde in vivo and was determined in these studies as a means of choosing appropriate dose levels for the in vivo genotoxicity experiments. Results presented in Fig. 2 indicate that hepatic glutathione levels are depleted below 30% of control values 1.5 hr after a single ip dose of 0.9 mmol/kg of 2-chloroethanol. Whereas the published LDsO for ip administration of 2-chloroethanol to male mice is 1.2 mmol/kg (Lawrence et al., 1972) , a range of dose levels from 0.9 to 1.2 mmol/kg was selected for the in vivo genotoxicity experiments.
The acute toxicity of 2-chloroethanol in this dose range was investigated in separate n Male B6C3Fi mice were killed 24 hr after ip administration of DCE, saline, or CC&. Diethyl maleate was administered ip 1 hr before 2-chloroethanol. All values are X f SD for 3 to 6 B6C3Fi mice per group.
b Organ weight per 100 g body wt.
' IDH, L-iditol dehydrogenase (EC 1.1.1.14); AAT, alanine aminotransferase (EC 2.6.1.2). dSignilicantly different from control, (P < 0.05) by one-way analysis of variance with multiple comparisons by the Bonferroni method (Neter and Wasserman, 1974). experiments. Results presented in Table 4 indicate that 2-chIoroethanol was hepatotoxic only at the highest dose level tested, 1.2 mmol/kg.
Pretreatment with DEM potentiated the acute toxicity of 2-chloroethanol indicating, as expected, a protective effect of glutathione. Mice pretreated with 3.0 mmol/ kg of diethyl maleate 1 hr before 0.9 mmol/ kg of 2-chloroethanol experienced high mortality and significantly increased liver to body weight ratios and serum enzyme activities.
The results of the in vivo genotoxicity experiments with 2-chloroethanol are presented in Table 5 . Four hours after ip administration of 2-chloroethanol at doses as high as 1.2 mmol/kg, there was no evidence of single-strand breaks and/or alkali-labile lesions in hepatic DNA. Pretreatment of mice with DEM to deplete hepatic glutathione prior to 2-chloroethanol administration also failed to produce a significant genotoxic effect. These results strongly suggest that 2-chloroethanol and 2-chloroacetaldehyde are not responsible for the hepatic DNA damage observed in these studies 4 hr after DCE administration.
DISCUSSION
PIB is a potent inhibitor of cytochrome P-450 monooxygenase activity. A methylenedioxyphenyl compound, it forms stable, metabolic intermediate complexes with cytochrome P-450 both in vitro and in vivo (Franklin, 1977) . The potentiation of the in vivo genotoxicity of DCE observed after PIB pretreatment therefore suggests that either the overall flux of DCE through an alternate bioactivation pathway is increased or the activity of a detoxification pathway is decreased as a consequence of the inhibition of microsomal, cytochrome P-450-mediated, oxidative metabolism. However, since microsomal oxidative metabolism is not known to be involved in the detoxification of any of the known or suspected reactive metabolites of DCE, it would appear that the data indicate an enhanced activity of an alternate pathway of metabolic activation. The only other activation pathway for DCE that has been identified to date is the direct conjugation of DCE with glutathione mediated by the glutathione S-transferases. Thus, it would appear that the most plausible explanation for the potentiation of the in vivo genotoxicity of DCE observed after PIB pretreatment is an increase in the total amount of reactive metabolites generated by the glutathione conjugation pathway. White et al. (1983) have recently shown that deuterium substitution inhibits the microsomal oxidative metabolism of 1,2-dibromoethane (DBE) in vitro and decreases its rate of clearance from the liver in vivo.
When the genotoxicities of DBE and tetradeutero-DBE were compared in an in vivo assay for single-strand breaks and alkali-labile lesions in DNA (alkaline elution), these authors found that the deuterium substitutions significantly increased the genotoxicity of DBE. They concluded, as we have here for DCE, that the increased genotoxicity, observed under conditions where microsomal oxidative metabolism was inhibited, strongly suggests that a product of the direct glutathione conjugation pathway is responsible for the hepatic DNA damage observed. The prolonged availability of DBE in the liver for glutathione conjugation was cited as a likely explanation for the potentiating effect of deuterium substitution. Thus, two, independent investigations of the role of microsomal oxidative metabolism in the in vivo genotoxicity of 1,2-dihaloethanes have produced similar results which suggest a primary role for active metabolites of the glutathione conjugation pathway in the production of the singlestrand breaks observed in alkaline DNA fragmentation assays. In addition, Ozawa and Guengerich ( 1983) have demostrated the formation of an 9[2-(N'-guanyl)ethyl]glutathione adduct in DNA incubated with DBE, GSH, and glutathione Stransferases.
The negative results from the in vivo genotoxicity assays of 2-chloroethanol provide further evidence for the primary role of the glutathione conjugation pathway in the in vivo genotoxicity of DCE. The glutathione depleting effect of 2-chloroethanol in vivo strongly suggests the intracellular production of significant amounts of 2-chloroacetaldehyde since, as shown by Johnson (1966) , 2-chloroethanol itself is not a good substrate for glutathione S-transferase. The negative results might suggest that glutathione conjugation effectively detoxifies the 2-chloroacetaldehyde formed before it can diffuse to the nucleus, but no hepatic DNA damage was seen after pretreatment with 3.0 mmol/kg DEM. This pretreatment reduced the hepatic glutathione level to 30% of control values at
